Fat-Soluble Vitamins & Micronutrients: Vitamins A and E and Carotenoids
Serum trans-
On this Page
Table 2.8.a. Serum trans-lycopene: Total population
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the total U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 3 years and older |
20.5 |
(19.8-21.1) |
10.5 |
(10.0-11.0) |
22.0 |
(21.2-22.8) |
37.5 |
(36.1-38.6) |
8348 |
3–5 years |
16.1 |
(15.2-17.1) |
7.90 |
(7.30-8.90) |
17.4 |
(16.2-18.1) |
30.7 |
(28.5-32.8) |
427 |
6–11 years |
21.6 |
(20.7-22.5) |
11.4 |
(10.4-12.7) |
22.7 |
(21.4-23.7) |
36.0 |
(35.0-37.2) |
1012 |
12–19 years |
21.6 |
(21.1-22.1) |
12.8 |
(11.9-13.6) |
22.3 |
(21.8-22.8) |
36.1 |
(35.1-37.5) |
2205 |
20–39 years |
22.7 |
(21.5-23.9) |
12.5 |
(11.7-13.8) |
23.7 |
(22.5-24.8) |
39.1 |
(37.6-41.0) |
1714 |
40–59 years |
21.1 |
(20.1-22.1) |
10.7 |
(9.80-11.7) |
22.6 |
(21.3-24.1) |
38.1 |
(36.6-39.8) |
1468 |
60 years and older |
15.4 |
(14.6-16.3) |
6.70 |
(5.70-7.30) |
17.1 |
(15.9-17.9) |
33.4 |
(31.5-34.5) |
1522 |
Males |
Total, 3 years and older |
21.2 |
(20.5-22.0) |
10.8 |
(10.3-11.3) |
23.1 |
(22.2-24.0) |
39.0 |
(37.4-40.6) |
4048 |
3–5 years |
16.0 |
(14.9-17.2) |
7.80 |
(7.10-9.00) |
17.7 |
(16.0-19.1) |
28.4 |
(27.1-30.9) |
216 |
6–11 years |
21.7 |
(20.4-23.1) |
11.5 |
(9.40-13.3) |
23.0 |
(21.2-25.0) |
36.4 |
(34.1-40.1) |
507 |
12–19 years |
22.5 |
(21.8-23.2) |
13.4 |
(12.4-14.0) |
23.5 |
(22.5-24.5) |
37.5 |
(35.3-39.8) |
1091 |
20–39 years |
24.2 |
(22.6-25.9) |
13.8 |
(11.7-15.0) |
25.0 |
(23.6-26.3) |
42.1 |
(39.1-45.2) |
724 |
40–59 years |
21.7 |
(20.4-23.2) |
11.1 |
(9.20-11.9) |
23.7 |
(21.9-25.5) |
39.8 |
(37.5-41.7) |
761 |
60 years and older |
15.2 |
(14.1-16.4) |
6.30 |
(5.60-7.50) |
16.8 |
(15.5-17.9) |
33.2 |
(30.5-36.0) |
749 |
Females |
Total, 3 years and older |
19.7 |
(19.1-20.4) |
10.3 |
(9.70-10.9) |
21.1 |
(20.1-21.9) |
35.6 |
(34.3-36.7) |
4300 |
3–5 years |
16.2 |
(14.6-18.1) |
8.00 |
(6.20-10.3) |
16.6 |
(14.9-18.6) |
32.5 |
(29.1-34.3) |
211 |
6–11 years |
21.5 |
(20.6-22.4) |
10.7 |
(9.70-13.0) |
22.2 |
(20.6-23.3) |
35.5 |
(34.1-37.3) |
505 |
12–19 years |
20.6 |
(20.0-21.3) |
12.3 |
(11.5-13.1) |
21.4 |
(20.0-22.2) |
34.8 |
(32.1-36.3) |
1114 |
20–39 years |
21.3 |
(20.2-22.5) |
12.2 |
(10.5-13.6) |
22.3 |
(21.2-23.6) |
36.7 |
(33.8-39.3) |
990 |
40–59 years |
20.4 |
(19.4-21.4) |
10.7 |
(9.30-12.1) |
21.8 |
(20.9-22.8) |
36.5 |
(34.4-37.8) |
707 |
60 years and older |
15.6 |
(14.5-16.9) |
6.70 |
(5.60-7.50) |
17.3 |
(15.7-18.6) |
33.3 |
(30.6-34.5) |
773 |
Table 2.8.b. Serum trans-lycopene: Mexican Americans
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for Mexican Americans in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 3 years and older |
19.7 |
(18.9-20.5) |
10.6 |
(9.90-11.6) |
20.6 |
(19.8-21.5) |
34.6 |
(33.0-36.0) |
2111 |
3–5 years |
15.0 |
(12.9-17.4) |
7.30 |
(5.80-9.20) |
15.7 |
(12.5-19.4) |
30.4 |
(23.0-39.8) |
124 |
6–11 years |
19.7 |
(18.3-21.3) |
10.5 |
(9.20-13.1) |
20.5 |
(18.7-22.5) |
33.7 |
(29.6-36.1) |
289 |
12–19 years |
20.4 |
(19.4-21.4) |
12.3 |
(11.2-13.4) |
20.7 |
(19.6-22.0) |
32.9 |
(30.4-36.2) |
696 |
20–39 years |
21.4 |
(20.1-22.8) |
12.1 |
(11.2-13.6) |
21.7 |
(20.6-22.5) |
36.0 |
(33.1-39.9) |
460 |
40–59 years |
19.1 |
(17.5-20.9) |
10.2 |
(8.70-11.3) |
20.0 |
(17.9-22.3) |
34.4 |
(29.9-39.1) |
287 |
60 years and older |
13.9 |
(11.7-16.6) |
6.20 |
(2.20-9.60) |
15.3 |
(13.1-17.7) |
30.1 |
(26.6-31.6) |
255 |
Males |
Total, 3 years and older |
20.4 |
(19.6-21.2) |
11.4 |
(10.2-12.0) |
21.3 |
(20.6-21.9) |
35.9 |
(32.7-39.4) |
1018 |
3–5 years |
15.2 |
(13.3-17.2) |
8.60† |
(1.80-11.3) |
15.7 |
(12.4-18.1) |
28.5† |
(23.8-33.3) |
62 |
6–11 years |
20.8 |
(18.5-23.4) |
12.6 |
(8.70-14.7) |
20.6 |
(19.2-24.1) |
33.4 |
(28.4-45.7) |
140 |
12–19 years |
21.1 |
(20.2-22.0) |
12.9 |
(11.6-13.9) |
21.5 |
(20.4-22.6) |
34.6 |
(30.3-39.4) |
330 |
20–39 years |
22.0 |
(20.7-23.5) |
12.4 |
(11.2-14.1) |
22.2 |
(20.7-23.6) |
39.1 |
(33.0-43.7) |
213 |
40–59 years |
20.0 |
(17.9-22.3) |
10.2 |
(8.90-11.8) |
20.9 |
(16.8-24.5) |
35.5 |
(30.2-43.3) |
147 |
60 years and older |
13.0 |
(10.4-16.3) |
5.20 |
(.800-7.50) |
14.2 |
(10.6-17.7) |
27.8 |
(24.0-31.4) |
126 |
Females |
Total, 3 years and older |
19.0 |
(18.0-20.0) |
10.2 |
(9.10-11.3) |
20.0 |
(18.6-21.4) |
33.7 |
(31.6-34.9) |
1093 |
3–5 years |
14.8 |
(11.0-19.8) |
6.70† |
(4.30-9.50) |
15.0 |
(9.50-22.8) |
32.7† |
(20.3-37.9) |
62 |
6–11 years |
18.7 |
(16.8-20.7) |
9.90 |
(9.10-11.0) |
20.0 |
(16.9-22.9) |
33.2 |
(28.6-35.4) |
149 |
12–19 years |
19.6 |
(18.4-20.9) |
11.7 |
(10.2-13.6) |
19.8 |
(18.3-21.2) |
31.7 |
(29.7-35.9) |
366 |
20–39 years |
20.6 |
(18.9-22.5) |
11.6 |
(10.3-13.2) |
21.3 |
(19.0-22.7) |
34.8 |
(30.1-37.6) |
247 |
40–59 years |
18.2 |
(16.4-20.2) |
9.10 |
(5.30-13.2) |
19.3 |
(17.9-20.8) |
30.5 |
(28.2-36.9) |
140 |
60 years and older |
14.7 |
(12.1-18.0) |
6.80 |
(1.90-10.3) |
15.8 |
(13.7-20.7) |
30.5 |
(24.4-36.1) |
129 |
† Estimate is subject to greater uncertainty due to small cell size. |
Table 2.8.c. Serum trans-lycopene: Non-Hispanic blacks
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic blacks in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 3 years and older |
21.6 |
(21.0-22.3) |
10.9 |
(10.1-11.7) |
23.4 |
(22.1-24.2) |
40.1 |
(37.9-42.2) |
1992 |
3–5 years |
20.8 |
(18.3-23.6) |
10.9 |
(8.90-13.4) |
20.8 |
(18.6-24.9) |
40.9 |
(28.5-54.9) |
128 |
6–11 years |
25.9 |
(24.1-27.9) |
15.0 |
(13.1-16.8) |
27.1 |
(24.1-29.6) |
42.1 |
(36.7-47.1) |
340 |
12–19 years |
24.7 |
(23.6-25.8) |
13.9 |
(12.4-16.0) |
25.4 |
(24.0-27.0) |
41.0 |
(38.4-43.0) |
671 |
20–39 years |
24.3 |
(23.3-25.4) |
13.1 |
(12.4-14.6) |
25.2 |
(23.5-26.8) |
41.6 |
(39.0-46.9) |
319 |
40–59 years |
19.0 |
(17.7-20.5) |
8.70 |
(6.20-11.3) |
20.6 |
(19.6-22.0) |
35.9 |
(34.4-41.3) |
291 |
60 years and older |
14.1 |
(12.9-15.4) |
5.40 |
(4.50-7.10) |
14.5 |
(13.3-16.7) |
31.4 |
(28.8-34.1) |
243 |
Males |
Total, 3 years and older |
22.3 |
(21.4-23.2) |
10.7 |
(9.90-12.4) |
23.8 |
(22.8-24.6) |
41.2 |
(37.4-44.1) |
984 |
3–5 years |
21.6 |
(18.2-25.5) |
9.90† |
(5.10-15.1) |
23.8 |
(19.3-27.0) |
41.7† |
(30.5-57.7) |
64 |
6–11 years |
27.1 |
(24.3-30.1) |
15.9 |
(13.0-18.5) |
28.0 |
(23.9-32.2) |
44.0 |
(36.4-49.1) |
175 |
12–19 years |
25.1 |
(23.9-26.4) |
15.2 |
(13.4-16.7) |
25.9 |
(24.4-27.6) |
40.1 |
(36.8-44.6) |
340 |
20–39 years |
25.6 |
(24.4-26.9) |
14.2 |
(12.5-16.2) |
26.5 |
(23.8-28.1) |
45.3 |
(37.4-56.2) |
132 |
40–59 years |
19.4 |
(17.8-21.0) |
9.20 |
(6.20-11.2) |
21.3 |
(19.3-22.7) |
35.7 |
(32.4-41.2) |
154 |
60 years and older |
13.5 |
(11.8-15.4) |
5.40 |
(4.30-7.10) |
14.0 |
(11.4-16.4) |
30.9 |
(26.2-34.9) |
119 |
Females |
Total, 3 years and older |
21.1 |
(20.2-22.0) |
11.0 |
(10.1-11.6) |
22.6 |
(20.9-24.2) |
39.7 |
(37.1-41.3) |
1008 |
3–5 years |
20.0 |
(17.2-23.2) |
11.1† |
(7.60-14.4) |
19.6 |
(15.7-25.5) |
40.9† |
(26.3-44.6) |
64 |
6–11 years |
24.7 |
(22.7-26.9) |
13.8 |
(11.7-16.8) |
25.9 |
(23.6-28.2) |
39.2 |
(35.2-44.8) |
165 |
12–19 years |
24.3 |
(22.7-26.0) |
12.5 |
(11.3-15.8) |
25.2 |
(22.7-27.6) |
41.0 |
(38.8-44.4) |
331 |
20–39 years |
23.5 |
(22.1-25.0) |
13.0 |
(11.8-14.6) |
24.4 |
(22.1-26.6) |
39.7 |
(37.1-46.5) |
187 |
40–59 years |
18.7 |
(16.9-20.7) |
7.90 |
(5.40-11.9) |
19.9 |
(17.7-22.0) |
36.2 |
(30.9-43.9) |
137 |
60 years and older |
14.5 |
(12.8-16.5) |
5.60 |
(4.50-8.20) |
14.8 |
(12.5-18.6) |
31.4 |
(28.0-34.1) |
124 |
† Estimate is subject to greater uncertainty due to small cell size. |
Table 2.8.d. Serum trans-lycopene: Non-Hispanic whites
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for non-Hispanic whites in the U.S. population aged 3 years and older, National Health and Nutrition Examination Survey, 2001–2002. |
|
Geometric mean
(95% conf. interval) |
Selected percentiles (95% conf. interval) |
Sample
size |
|
10th |
50th |
90th |
Males and Females |
Total, 3 years and older |
20.7 |
(19.9-21.4) |
10.8 |
(10.2-11.4) |
22.1 |
(21.0-23.2) |
37.6 |
(36.3-38.7) |
3578 |
3–5 years |
15.4 |
(14.0-17.0) |
7.90 |
(6.20-9.30) |
16.6 |
(14.8-17.9) |
27.5 |
(25.3-31.2) |
132 |
6–11 years |
21.5 |
(20.2-22.9) |
11.4 |
(9.70-13.2) |
22.2 |
(20.6-23.6) |
35.8 |
(33.3-37.8) |
300 |
12–19 years |
21.1 |
(20.5-21.8) |
12.8 |
(11.5-13.8) |
21.9 |
(20.8-22.6) |
35.3 |
(34.0-36.8) |
656 |
20–39 years |
22.9 |
(21.3-24.6) |
13.1 |
(11.7-14.2) |
24.2 |
(22.8-25.7) |
39.6 |
(37.7-42.1) |
770 |
40–59 years |
21.9 |
(20.7-23.1) |
11.8 |
(10.3-13.4) |
23.2 |
(21.3-24.9) |
38.5 |
(36.8-40.0) |
777 |
60 years and older |
16.1 |
(15.2-17.0) |
7.00 |
(6.20-7.70) |
17.8 |
(16.4-18.6) |
33.9 |
(31.7-35.9) |
943 |
Males |
Total, 3 years and older |
21.4 |
(20.5-22.4) |
11.0 |
(9.90-11.6) |
23.5 |
(22.3-24.5) |
39.5 |
(37.9-40.9) |
1737 |
3–5 years |
14.4 |
(12.6-16.5) |
7.80† |
(4.40-9.50) |
16.4 |
(14.3-19.1) |
27.4† |
(24.7-30.9) |
71 |
6–11 years |
21.7 |
(19.9-23.6) |
12.2 |
(9.40-14.1) |
22.2 |
(20.3-25.2) |
36.0 |
(32.0-40.1) |
157 |
12–19 years |
22.1 |
(21.2-23.1) |
12.9 |
(11.5-14.0) |
23.2 |
(21.4-24.6) |
37.0 |
(34.3-40.2) |
323 |
20–39 years |
24.8 |
(22.4-27.3) |
13.9 |
(11.1-16.6) |
25.8 |
(23.9-28.9) |
42.4 |
(38.8-45.6) |
312 |
40–59 years |
22.6 |
(21.0-24.2) |
11.4 |
(9.20-13.5) |
24.5 |
(22.4-26.9) |
40.0 |
(37.9-42.9) |
407 |
60 years and older |
15.7 |
(14.6-17.0) |
6.90 |
(5.80-7.70) |
17.5 |
(15.7-18.6) |
33.8 |
(30.6-37.6) |
467 |
Females |
Total, 3 years and older |
19.9 |
(19.2-20.7) |
10.6 |
(9.90-11.4) |
21.1 |
(20.1-22.1) |
35.4 |
(33.9-36.7) |
1841 |
3–5 years |
16.6 |
(14.7-18.8) |
8.70† |
(6.20-13.1) |
16.6 |
(14.7-18.9) |
26.8† |
(22.8-31.8) |
61 |
6–11 years |
21.3 |
(19.8-22.9) |
11.0 |
(9.40-13.8) |
21.7 |
(20.0-23.7) |
34.2 |
(32.5-38.0) |
143 |
12–19 years |
20.2 |
(19.4-21.0) |
12.6 |
(11.0-13.9) |
21.3 |
(19.4-22.2) |
32.4 |
(28.9-35.8) |
333 |
20–39 years |
21.3 |
(19.8-23.0) |
12.3 |
(9.40-14.3) |
22.4 |
(20.9-24.1) |
36.5 |
(33.1-39.6) |
458 |
40–59 years |
21.2 |
(20.2-22.3) |
12.6 |
(10.7-13.7) |
22.0 |
(20.7-23.5) |
36.6 |
(34.0-37.8) |
370 |
60 years and older |
16.4 |
(15.1-17.7) |
6.90 |
(5.70-8.40) |
17.9 |
(15.9-19.0) |
33.8 |
(31.4-36.1) |
476 |
† Estimate is subject to greater uncertainty due to small cell size. |